ArticleDiabetes care2022

Comparative Safety of Sodium-Glucose Cotransporter 2 Inhibitors Versus Dipeptidyl Peptidase 4 Inhibitors and Sulfonylureas on the Risk of Diabetic Ketoacidosis.

Ghadeer K Dawwas et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.